Best Practice & Research Clinical Anaesthesiology
Volume 22, Issue 1 , Pages 23-37 , March 2008

Pharmacogenomics and end-organ susceptibility to injury in the perioperative period

  • Debra A. Schwinn, MD (Professor and Chair of Anesthesiology)

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +1 (206) 543 2673; Fax: +1 (206) 543 2958.

References 

  1. Kozak LJ, Owings MF, Hall MJ. National Hospital Discharge Survey: 2002 annual summary with detailed diagnosis and procedure data. Vital and Health Statistics 13. 2005 Mar;(158):1–199
  2. Podgoreanu MV, Schwinn DA. New paradigms in cardiovascular medicine: emerging technologies and practices: perioperative genomics. Journal of the American College of Cardiology. 2005 Dec 6;46(11):1965–1977
  3. Podgoreanu MV, White WD, Morris RW, et al. Inflammatory gene polymorphisms and risk of postoperative myocardial infarction following cardiac surgery. Circulation. 2006;114:275–281
  4. Newby LK, Alpert JS, Ohman EM, et al. Changing the diagnosis of acute myocardial infarction: implications for practice and clinical investigations. American Heart Journal. 2002;144:957–980
  5. Ishii Y, Schuessler RB, Gaynor SL, et al. Inflammation of atrium after cardiac surgery is associated with inhomogeneity of atrial conduction and atrial fibrillation. Circulation. 2005;111:2881–2888
  6. Mielck F, Ziarkowski A, Hanekop G, et al. Cerebral inflammatory response during and after cardiac surgery. European Journal of Anaesthesiology. 2005 May;22(5):347–352
  7. Maggio M, Ceda BP, De Cicco G, et al. Acute changes in circulating hormones in older patients with impaired ventricular function undergoing on-pump coronary artery bypass grafting. Journal of Endocrinological Investigation. 2005;28:711–719
  8. Chang A. Inflammatory mediators in children undergoing cardiopulmonary bypass: is there a unified field theory amidst this biomolecular chaos?. Pediatric Critical Care Medicine. 2003;4:386–387
  9. Krinsley J. Perioperative glucose control. Current Opinion in Anaesthesiology. 2006;19:111–116
  10. Gandhi GY, Nuttall GA, Abel MD, et al. Intraoperative hyperglycemia and perioperative outcomes in cardiac surgery patients. Mayo Clinic Proceedings. 2005 Jul;80(7):862–866
  11. Pittas AG, Siegel RD, Lau J. Insulin therapy and in-hospital mortality in critically ill patients: systematic review and meta-analysis of randomized controlled trials. JPEN. Journal of Parenteral and Enteral Nutrition. 2006;30:164–172
  12. Devaraj S, Venugopal SK, Singh U, Jialal I. Hyperglycemia induces monocytic release of interleukin-6 via induction of protein kinase C-{alpha} and -{beta}. Diabetes. 2005 January 1;54(1):85–91
  13. Desvergne B, Michalik L, Wahli W. Transcriptional regulation of metabolism. Physiological Reviews. 2006;86:465–514
  14. Scirica BM, Morrow DA. Is C-reactive protein an innocent bystander or proatherogenic culprit?. Circulation. 2006;113:2128–2151
  15. van Acker BA, Hulsewe KW, Wagenmakers AJ, et al. Glatamine appearance rate in plasma is not increased after gastrointestinal surgery in humans. The Journal of Nutrition. 2000;1566–1571
  16. Botfield C, Ross RJ, Hinds CJ. The role of IGFs in catabolism. Baillieres Clinical Endocrinology and Metabolism. 1997;11:679–697
  17. Tjader I, Essen P, Thorne A, et al. Muscle protein synthesis rate decreases 24hrs after abdominal surgery irrespective of total parenteral nutrition. JPEN. Journal of Parenteral and Enteral Nutrition. 1996;20:135–138
  18. Heindorff HA. The hepatic catabolic stress response: hormonal regulation of urea synthesis after surgery. Danish Medical Bulletin. 1993;40:224–234
  19. Ikonomidis I, Athanassopoulos G, Lekakis J, et al. Myocardial ischemia induces interleukin-6 and tissue factor production in patients with coronary artery disease: a dobutamine stress echocardiography study. Circulation. 2005;112:3272–3279
  20. Mao W, Iwai C, Keng PC, et al. Norepinephrine-induced oxidative stress causes PC-12 cell apoptosis by both endoplasmic reticulum stress and mitochondrial intrinsic pathway: inhibition of phosphatidylinositol 3-kinase survival pathway. American Journal of Physiology. Cell Physiology. 2006;290:C1373–C1384
  21. Dennis SC, Gevers W, Opie LH. Protons in ischemia: where do they come from; where do they go to?. Journal of Molecular and Cellular Cardiology. 1991;23:1077–1086
  22. Ockaili R, Natarajan R, Salloum F, et al. HIF-1 activation attenuates postischemic myocardial injury: role for heme oxygenase-1 in modulating microvascular chemokine generation. American Journal of Physiology. Heart and Circulatory Physiology. 2005;289:H542–H548
  23. Tsang A, Hausenloy DJ, Yellon DM. Myocardial postconditioning: reperfusion injury revisited. American Journal of Physiology. Heart and Circulatory Physiology. 2005;289:H2–H7
  24. Kutala VK, Khan M, Mandal R, et al. Attenuation of myocardial ischemia-reperfusion injury by trimetazidine derivatives functionalized with antioxidant properties. The Journal of Pharmacology and Experimental Therapeutics. 2006;317:921–928
  25. Churchill EN, Murriel CL, Chen C-H, et al. Reperfusion-induced translocation of delta PKC to cardiac mitochondria prevents pyruvate dehydrogenase reactivation. Circulation Research. 2005;97:78–85
  26. van Empel VPM, Bertrand AT, van der Nagel R, et al. Downregulation of apoptosis-inducing factor in Harlequin mutant mice sensitizes the myocardium to oxidative stress-related cell death and pressure overload-induced decompensation. Circulation Research. 2005;96:E92–E101
  27. Rui T, Kvietys PR. NFkB and AP-1 differentially contribute to the induction of Mn-SOD and eNOS during the development of oxidant tolerance. FASEB Journal. 2005;19:1908–1910
  28. Chong AJ, Pohlman TH, Hampton CR, et al. Tissue factor and thrombin mediate myocardial ischemia-reperfusion injury. Annals of Thoracic Surgery. 2003 Feb;75(2):S649–S655
  29. BelAiba RS, Djordjevic T, Bonello S, et al. The serum- and glucocorticoid-inducible kinase Sgk-1 is involved in pulmonary vascular remodeling: role in redox-sensitive regulation of tissue factor by thrombin. Circulation Research. 2006;98:828–836
  30. Levy JH, Tanaka KA. Inflammatory response to cardiopulmonary bypass. Annals of Thoracic Surgery. 2003 Feb;75(2):S715–S720
  31. Rinder CS, Mathew JP, Rinder HM, et al. Platelet PlA2 polymorphism and platelet activation are associated with increased troponin I release after cardiopulmonary bypass. Anesthesiology. 2002 Nov;97(5):1118–1122
  32. Nadra I, Mason JC, Philippidis P, et al. Proinflammatory activation of macrophages by basic calcium phosphate crystals via protein kinase C and MAP kinase pathways: a vicious cycle of inflammation and arterial calcification. Circulation Research. 2005;96:1248–1256
  33. Goldstein JI, Goldstein KA, Wardwell K, et al. Increase in plasma and surface CD163 levels in patients undergoing coronary artery bypass graft surgery. Atherosclerosis. 2003;170:325–332
  34. Christenson RH, deFilippi CP, Kreutzer D. Biomarkers of ischemia in patients with known coronary artery disease: do interleukin-6 and tissue factor measurements during dobutamine stress echocardogarphy give additional insight?. Circulation. 2005;112:3215–3217
  35. Ikonomidis I, Andreotti F, Nihoyannopoulos P. Reduction of daily-life ischaemia by aspirin in patients with angina: underlying link between thromboxane A2 and macrophage colony stimulating factor. Heart. 2004;90:389–393
  36. Rother RP, Bell L, Hillmen P, Gladwin MT. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. The Journal of the American Medical Association. 2005;293:1653–1662
  37. Pasceri V, Pristipino C, Pelliccia F, et al. Effects of the nitric oxide donor nitroprusside on no-reflow phenomenon during coronary interventions for acute myocardial infarction. American Journal of Cardiology. 2005;95:1358–1361
  38. Zieker D, Elvira F, Dietzsch J, et al. cDNA microarray analysis reveals novel candidate genes expressed in human peripheral blood following exhaustive exercise. Physiological Genomics. 2005;23:287–294
  39. Hoffman-Goetz L, Pedersen BK. Exercise and the immune system: a model of the stress response?. Immunology Today. 1994;15:382–387
  40. Steenberg A, Fischer CP, Keller C, et al. IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans. American Journal of Physiology. Endocrinology and Metabolism. 2003;285:E433–E437
  41. Niess AM, Dickhuth HH, Northoff H, Fehrenbach E. Free radicals and oxidative stress in exercise – immulogic aspects. Exercise Immunology Review. 1999;5:22–56
  42. Russell AP, Hesselink MKC, Lo SK, Schrauwen P. Regulation of metabolic transcriptional co-activators and transcription factors with acute exercise. FASEB Journal. 2005;19:986–988
  43. Talwar S, Munson PJ, Barb J, et al. Gene expression profiles of peripheral blood leukocytes after endotoxin challenge in humans. Physiological Genomics. 2006;25:203–215
  44. Calvano SE, Xiao W, Richards DR, et al. A network-based analysis of systemic inflammation in humans. Nature. 2005;437:1032–1037
  45. Wada Y, Otu H, Wu S, et al. Preconditioning of primary human endothelial cells with inflammatory mediators alters the “set point” of the cell. FASEB Journal. 2005;19:1914–1916
  46. Fox AA, Shernan SK, Body SC. Predictive genomics of adverse events after cardiac surgery. Seminars in Cardiothoracic and Vascular Anesthesia. 2004 Dec;8(4):297–315
  47. Stuber F, Hoeft A. The influence of genomics on outcome after cardiovascular surgery. Current Opinion in Anaesthesiology. 2002;15:3–8
  48. Ziegeler S, Tsusaki BE, Collard CD. Influence of genotype on perioperative risk and outcome. Anesthesiology. 2003 Jul;99(1):212–219
  49. Donahue BS, Balser JR. Perioperative genomics. Venturing into uncharted seas. Anesthesiology. 2003 Jul;99(1):7–8
  50. Broeckel U, Hengstenberg C, Mayer B, et al. A comprehensive linkage analysis for myocardial infarction and its related risk factors. Nature Genetics. 2002 Feb;30(2):210–214
  51. Gretarsdottir S, Sveinbjornsdottir S, Jonsson HH, et al. Localization of a susceptibility gene for common forms of stroke to 5q12. American Journal of Human Genetics. 2002 Mar;70(3):593–603
  52. Knight JC. Regulatory polymorphisms underlying complex disease traits. Journal of Molecular Medicine. 2005 Feb;83(2):97–109
  53. Faraday N, Martinez EA, Scharpf RB, et al. Platelet gene polymorphisms and cardiac risk assessment in vascular surgical patients. Anesthesiology. 2004 Dec;101(6):1291–1297
  54. Gaudino M, Andreotti F, Zamparelli R, et al. The −174G/C interleukin-6 polymorphism influences postoperative interleukin-6 levels and postoperative atrial fibrillation. Is atrial fibrillation an inflammatory complication?. Circulation. 2003 Sep 9;108(supplment 1):II195–II199
  55. Ortlepp JR, Hoffmann R, Killian A, et al. The 4G/5G promotor polymorphism of the plasminogen activator inhibitor-1 gene and late lumen loss after coronary stent placement in smoking and nonsmoking patients. Clinical Cardiology. 2001 Sep;24(9):585–591
  56. Holweg CT, Weimar W, Uitterlinden AG, Baan CC. Clinical impact of cytokine gene polymorphisms in heart and lung transplantation. The Journal of Heart and Lung Transplantation. 2004 Sep;23(9):1017–1026
  57. MacKensen GB, Swaminathan M, Ti LK, et al. Preliminary report on the interaction of apolipoprotein E polymorphism with aortic atherosclerosis and acute nephropathy after CABG. Annals of Thoracic Surgery. 2004 Aug;78(2):520–526
  58. Stafford-Smith M, Podgoreanu M, Swaminathan M, et al. Association of genetic polymorphisms with risk of renal injury after coronary bypass graft surgery. American Journal of Kidney Diseases. 2005 Mar;45(3):519–530
  59. Mathew JP, Rinder CS, Howe JG, et al. Platelet PlA2 polymorphism enhances risk of neurocognitive decline after cardiopulmonary bypass. Multicenter Study of Perioperative Ischemia (McSPI) Research Group. Annals of Thoracic Surgery. 2001 Feb;71(2):663–666
  60. Tardiff BE, Newman MF, Saunders AM, et al. Preliminary report of a genetic basis for cognitive decline after cardiac operations. The Neurologic Outcome Research Group of the Duke Heart Center. Annals of Thoracic Surgery. 1997 Sep;64(3):715–720
  61. Grocott HP, White WD, Morris RW, et al. Genetic polymorphisms and the risk of stroke after cardiac surgery. Stroke. 2005 Jul 28;
  62. Zotz RB, Klein M, Dauben HP, et al. Prospective analysis after coronary-artery bypass grafting: platelet GP IIIa polymorphism (HPA-1b/PIA2) is a risk factor for bypass occlusion, myocardial infarction, and death. Thrombosis and Haemostasis. 2000 Mar;83(3):404–407
  63. Welsby IJ, Podgoreanu MV, Phillips-Bute B, et al. Genetic factors contribute to bleeding after cardiac surgery. Journal of Thrombosis and Haemostasis. 2005 Jun;3(6):1206–1212
  64. Donahue BS, Gailani D, Higgins MS, et al. Factor V Leiden protects against blood loss and transfusion after cardiac surgery. Circulation. 2003 Feb 25;107(7):1003–1008
  65. Moretti EW, Morris RW, Podgoreanu M, et al. APOE polymorphism is associated with risk of severe sepsis in surgical patients. Critical Care Medicine. 2005;33:2521–2526
  66. Stuber F, Petersen M, Bokelmann F, Schade U. A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-alpha concentrations and outcome of patients with severe sepsis. Critical Care Medicine. 1996 Mar;24(3):381–384
  67. Brull DJ, Montgomery HE, Sanders J, et al. Interleukin-6 gene −174g>c and −572g>c promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery. Arteriosclerosis Thrombosis and Vascular Biology. 2001 Sep;21(9):1458–1463
  68. Burzotta F, Iacoviello L, Di Castelnuovo A, et al. Relation of the −174 G/C polymorphism of interleukin-6 to interleukin-6 plasma levels and to length of hospitalization after surgical coronary revascularization. American Journal of Cardiology. 2001 Nov 15;88(10):1125–1128
  69. Grocott HP, Newman MF, El-Moalem H, et al. Apolipoprotein E genotype differentially influences the proinflammatory and anti-inflammatory response to cardiopulmonary bypass. The Journal of Thoracic and Cardiovascular Surgery. 2001 Sep;122(3):622–623
  70. Roth-Isigkeit A, Hasselbach L, Ocklitz E, et al. Inter-individual differences in cytokine release in patients undergoing cardiac surgery with cardiopulmonary bypass. Clinical and Experimental Immunology. 2001 Jul;125(1):80–88
  71. Galley HF, Lowe PR, Carmichael RL, Webster NR. Genotype and interleukin-10 responses after cardiopulmonary bypass. British Journal of Anaesthesia. 2003 Sep;91(3):424–426
  72. Shaw AD, Vaporciyan AA, Wu X, et al. Inflammatory gene polymorphisms influence risk of postoperative morbidity after lung resection. Annals of Thoracic Surgery. 2005 May;79(5):1704–1710
  73. Viant MR, Rosenblum ES, Tieerdema RS. NMR-based metabolomics: a powerful approach for characterizing the effects of environmental stressors on organism health. Environmental Science & Technology. 2003 Nov 1;37(21):4982–4989
  74. Serkova N, Fuller TF, Klawitter J, et al. H-NMR-based metabolic signatures of mild and severe ischemia/reperfusion injury in rat kidney transplants. Kidney International. 2005 Mar;67(3):1142–1151
  75. Singleton KD, Serkova N, Beckey VE, Wischmeyer PE. Glutamine attenuates lung injury and improves survival after sepsis: role of enhanced heat shock protein expression. Critical Care Medicine. 2005 Jun;33(6):1206–1213
  76. Wischmeyer PE, Jayakar D, Williams U, et al. Single dose of glutamine enhances myocardial tissue metabolism, glutathione content, and improves myocardial function after ischemia-reperfusion injury. JPEN. Journal of Parenteral and Enteral Nutrition. 2003 Nov–Dec;27(6):396–403
  77. Sabatine MS, Emerson L, Morrow DA, et al. Metabolomic identification of novel biomarkers of myocardial ischemia. Circulation. 2005;112:3868–3875
  78. Steed L, Kong R, Stygall J, et al. The role of apolipoprotein E in cognitive decline after cardiac operation. Annals of Thoracic Surgery. 2001 Mar;71(3):823–826
  79. Newman MF, Booth JV, Laskowitz DT, et al. Genetic predictors of perioperative neurological and cognitive injury and recovery. Best Practice and Research Clinical Anesthesiology. 2001;15(2):247–276
  80. Podgoreanu M, Lin S, Haystead T, et al. Genomic and proteomic profiling of occluded coronary saphenous vein grafts. Anesthesia & Analgesia. 2005;100:SCA71 (abstr)
  81. Podgoreanu MV, Schwinn DA. Genomics and the circulation. British Journal of Anaesthesia. 2004 Jul;93(1):140–148
  82. Borozdenkova S, Smith J, Marshall S, et al. Identification of ICAM-1 polymorphism that is associated with protection from transplant associated vasculopathy after cardiac transplantation. Human Immunology. 2001 Mar;62(3):247–255
  83. Puthothu B, Krueger M, Bernhardt M & Heinzmann A. ICAM1 amino-acid variant K469E is associated with paediatric bronchial asthma and elevated sICAM1 levels. Genes and Immunity. in press (epub online).
  84. Kawamura T, Umemura T, Kanai A, et al. Soluble adhesion molecules and C-reactive protein in the progression of silent cerebral infarction in patients with type 2 diabetes mellitus. Metabolism. 2006;55:461–466
  85. Kaplanski G, Marin V, Fabrigoule M, et al. Thrombin-activated human endothelial cells support monocyte adhesion in vitro following expression of intercellular adhesion molecule-1 (ICAM-1; CD54) and vascular cell adhesion molecule-1 (VCAM-1; CD106). Blood. 1998;92:1259–1267
  86. Collins PW, Noble KE, Reittie JR, et al. Induction of tissue factor expression in human monocyte/endothelium cocultures. British Journal of Haematology. 1995;91:963–970
  87. Coughlin SR. Protease-activated receptors in hemostasis, thrombosis, and vascular biology. Journal of Thrombosis and Haemostasis. 2005;3:1800–1814
  88. Armstrong EJ, Morrow DA, Sabatine MS. Inflammatory biomarkers in acute coronary syndromes: part II: acute-phase reactants and biomarkers of endothelial cell activation. Circulation. 2006;113:152–155
  89. Zheng F, Chevalier JA, Zhang LQ, et al. An HphI polymorphism in the E-selectin gene is associated with premature coronary artery disease. Clinical Genetics. 2001;59:58–64
  90. Ghilardi G, Biondi ML, Turri O, et al. Ser128Arg gene polymorphism for E-selectin and severity of atherosclerotic arterial disease. The Journal of Cardiovascular Surgery. 2004;45:143–147
  91. Jilma B, Marsik C, Kovar F, et al. The single nucleotide polymorphism Ser128Arg in the E-selectin gene is associated with enhanced coagulation during human endotoxemia. Blood. 2005;105:2380–2383
  92. Edelstein LC, Pan A, Collins T. Chromatin modification and the endothelial-specific activation of the E-selectin gene. The Journal of Biological Chemistry. 2005;280:11192–11202
  93. Joucher F, Mazmanian GM, German-Fattal M. E-selectin early overexpression induced by allogeneic activation in isolated mouse lung. Transplantation. 2004;78:1283–1289
  94. Meigs JB, Hu FB, Perhanidis JS, et al. E-selectin genotypes and risk of type 2 diabetes in women. Obesity Research. 2005;13:1845–1847
  95. Yu Y, Moulton KS, Khan MK, et al. E-selectin is required for the antiangiogenic activity of endostatin. Proceedings of the National Academy of Sciences of the United States of America. 2004;101:8005–8010
  96. Zanardo RC, Bonder CS, Hwang JM, et al. A down-regulatable E-selectin ligand is functionally important for PSGL-1-independent leukocyte-endothelial cell interactions. Blood. 2004;104:3766–3773
  97. Galimberti D, Fenoglio C, Clerici R, et al. E-selectin A561C and G98T polymorphisms influence susceptibilityand course of multiple sclerosis. Journal of Neuroimmunology. 2005;165:201–205
  98. Podgoreanu MV, Michelotti GA, Sato Y, et al. Differential cardiac gene expression during cardiopulmonary bypass: ischemia-independent upregulation of proinflammatory genes. The Journal of Thoracic and Cardiovascular Surgery. 2005 Aug;130(2):330–339
  99. Hakonarson H, Thorvaldsson S, Helgadottir A, et al. Effects of a 5-lipoxygenase-activating protein inhibitor on biomarkers associated with risk of myocardial infarction: a randomized trial. The Journal of the American Medical Association. 2005 May 11;293(18):2245–2256
  100. Helgadottir A, Manolescu A, Thorleifsson G, et al. The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nature Genetics. 2004 Mar;36(3):233–239

☆ Funding:

☆ Funding was provided in part by the U.S. National Institutes of Health grant #HL075273.

PII: S1521-6896(07)00085-7

doi: 10.1016/j.bpa.2007.09.005

Best Practice & Research Clinical Anaesthesiology
Volume 22, Issue 1 , Pages 23-37 , March 2008

Article Tools

* Image Usage & Resolution